AMENDMENT NO. 1 TO COMMON STOCK PURCHASE AGREEMENTCommon Stock Purchase Agreement • February 12th, 2010 • Oxigene Inc • Biological products, (no disgnostic substances) • New York
This Amendment No. 1 to the Common Stock Purchase Agreement, dated as of February 9, 2010 (the “Amendment”), to the Common Stock Purchase Agreement dated as of February 19, 2008 (the “Purchase Agreement”) is entered into by and between OXiGENE, Inc., a corporation organized and existing under the laws of the State of Delaware (the “Company”), and Kingsbridge Capital Limited, an entity organized and existing under the laws of the British Virgin Islands (the “Investor”).
